Literature DB >> 12847114

Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy.

Akimasa Koga1, Naoki Oka, Toshio Kikuchi, Hiroshi Miyazaki, Seiya Kato, Tsutomu Imaizumi.   

Abstract

Caveolae are omega-shaped organelles of the cell surface. The protein caveolin-3, a structural component of cardiac caveolae, is associated with cellular signaling. To investigate the effect of adenovirus-mediated overexpression of caveolin-3 on hypertrophic responses in cardiomyocytes, we constructed an adenovirus that encoded human wild-type caveolin-3 (Ad.Cav-3), mutant caveolin-3 (Ad.Cav-3Delta), or bacterial beta-galactosidase (Ad.LacZ). This mutant has been reported to cause human limb-girdle muscular dystrophy. It lacks 9 nucleotides in the caveolin scaffolding domain and behaves in a dominant-negative fashion. Rat neonatal cardiomyocytes were infected with the virus and then harvested 36 hours after infection. In noninfected cells, phenylephrine (PE) and endothelin-1 (ET) increased cell size and [3H]leucine incorporation, along with the induction of sarcomeric reorganization and the reexpression of beta-myosin heavy chain, indicating myocyte hypertrophy. Infection with Ad.LacZ had no effect on those parameters. Ad.Cav-3 prevented the PE- and ET-induced increases in cell size, leucine incorporation, sarcomeric reorganization, and reexpression of beta-myosin heavy chain. Ad.Cav-3 also blocked the PE- and ET-induced phosphorylations of extracellular signal-regulated kinases (ERKs) but did not affect c-Jun amino-terminal kinase and p38 mitogen-activated protein kinase activities. In contrast, Ad.Cav-3Delta significantly augmented hypertrophic responses to ET, which were associated with increased ET-induced phosphorylation of ERK1/2. These results suggest that caveolin-3 behaves as a negative regulator of hypertrophic responses, probably through suppression of ERK1/2 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847114     DOI: 10.1161/01.HYP.0000082926.08268.5D

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

Review 1.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

2.  Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes.

Authors:  Casey D Wright; Quanhai Chen; Nichole L Baye; Yuan Huang; Chastity L Healy; Sivakanthan Kasinathan; Timothy D O'Connell
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

Review 3.  Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

Authors:  Yousuke T Horikawa; Yasuo M Tsutsumi; Hemal H Patel; David M Roth
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Authors:  Yousuke T Horikawa; Mathivadhani Panneerselvam; Yoshitaka Kawaraguchi; Yasuo M Tsutsumi; Sameh S Ali; Ravi C Balijepalli; Fiona Murray; Brian P Head; Ingrid R Niesman; Timo Rieg; Volker Vallon; Paul A Insel; Hemal H Patel; David M Roth
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

Review 5.  Caveolins as Regulators of Stress Adaptation.

Authors:  Jan M Schilling; Brian P Head; Hemal H Patel
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

6.  Inducible Fgf13 ablation enhances caveolae-mediated cardioprotection during cardiac pressure overload.

Authors:  Eric Q Wei; Daniel S Sinden; Lan Mao; Hailin Zhang; Chuan Wang; Geoffrey S Pitt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

7.  Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels.

Authors:  Yogananda S Markandeya; Jonathan M Fahey; Florentina Pluteanu; Leanne L Cribbs; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

8.  Lipid raft in cardiac health and disease.

Authors:  Manika Das; Dipak K Das
Journal:  Curr Cardiol Rev       Date:  2009-05

Review 9.  Caveolinopathies: from the biology of caveolin-3 to human diseases.

Authors:  Elisabetta Gazzerro; Federica Sotgia; Claudio Bruno; Michael P Lisanti; Carlo Minetti
Journal:  Eur J Hum Genet       Date:  2009-07-08       Impact factor: 4.246

10.  Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection.

Authors:  Betti Giusti; Marina Marini; Luciana Rossi; Ilaria Lapini; Alberto Magi; Andrea Capalbo; Rosa Lapalombella; Simona di Tullio; Michele Samaja; Fabio Esposito; Vittoria Margonato; Maria Boddi; Rosanna Abbate; Arsenio Veicsteinas
Journal:  BMC Genomics       Date:  2009-07-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.